Cargando…
Hämovigilanz von Blutkomponenten Meldungen an das Paul-Ehrlich-Institut vom 1.1.1995 bis zum 15.11.1998: Meldungen an das Paul-Ehrlich-Institut vom 1.1.1995 bis zum 15.11.1998
In Germany cellular blood products are a licensed medicinal product. In the following we would like to present the reporting procedure, analysis and evaluation of suspected cases from spontaneously recorded data. During the time period from 1.1.95 until 1.1. 98 a total of 1488 suspected adverse even...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096064/ http://dx.doi.org/10.1007/s001030050075 |